Scientific and regulatory approaches to confirm quality and improve patient perceptions of generic drug products in Japan

Scientific and regulatory approaches to confirm quality and improve patient perceptions of generic drug products in Japan

Abstract The rapidly growing medical expense going with aging population in Japan requires the use of generic products derived from off-patent active pharmaceutical ingredients (APIs) formulations to reduce the financial burden for the national health insurance system, while at the same time avoidin...

Full description

Bibliographic Details
Main Authors: Hiroko Shibata, Hiroyuki Yoshida, Ken-ichi Izutsu, Chikako Yomota, Yukihiro Goda, Haruhiro Okuda
Format: Article
Language:English
Published: SpringerOpen 2016-10-01
Series:AAPS Open
Subjects:
Quality
Generic drugs
Japan
Expert Committee on Quality of Generic Drug Products
Bioequivalence
Online Access:http://link.springer.com/article/10.1186/s41120-016-0008-z

Internet

http://link.springer.com/article/10.1186/s41120-016-0008-z

Similar Items